Business Context and Reporting Period
The provided filing is an Annual Report on Form 10-K for Agrify Corporation (Nasdaq: AGFY), not RYTHM, Inc. It covers the fiscal year ended December 31, 2023 and was filed April 15, 2024. Agrify provides cultivation and extraction equipment, software, construction, engineering, and related services for cannabis and hemp operators.
The company’s principal offerings include Agrify Vertical Farming Units, Agrify Insights SaaS software, extraction and laboratory equipment, and total turnkey cultivation solutions. Management stated that it does not cultivate, process, distribute, or sell cannabis or cannabis derivatives.
Financial Performance and Liquidity
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $16.9 million | $58.3 million | Down 71% |
| Gross profit (loss) | $5.3 million | $(31.8) million | Improved $37.1 million |
| Gross margin | 31% | (55)% | Improved |
| Loss from operations | $(19.0) million | $(193.3) million | Improved $174.3 million |
| Net loss attributable to Agrify | $(18.6) million | $(188.2) million | Improved $169.5 million |
| Basic and diluted loss per share | $(12.51) | $(902.19) | Not directly comparable after reverse splits |
| Cash flow from operations | $(31.0) million | $(72.0) million | Improved $41.0 million |
| Cash flow from investing | $25.2 million | $(2.3) million | Improved $27.5 million |
| Cash flow from financing | $(4.2) million | $72.8 million | Down $77.0 million |
Revenue consisted of $14.7 million from extraction solutions, $1.1 million from cultivation solutions, $0.9 million from facility build-outs, and $0.2 million from Agrify Insights software. Extraction solutions represented approximately 87% of total revenue.
At December 31, 2023, Agrify had $0.4 million of cash and cash equivalents, $4 thousand of marketable securities, $24.0 million of current assets, and $41.2 million of current liabilities. Total liabilities were $60.0 million, including $21.3 million of debt, while stockholders’ deficit attributable to Agrify was $14.9 million.
Accumulated deficit was approximately $265.8 million. The company reported negative operating cash flow and disclosed substantial doubt about its ability to continue as a going concern. The financial statements do not include adjustments that could result if the company is unable to continue operations.
Material Changes Versus the Prior Comparable Period
- Revenue declined by $41.4 million, primarily because facility build-outs were substantially wound down and extraction revenue fell amid industry weakness and integration challenges.
- Facility build-out revenue decreased 96%, from $23.1 million to $0.9 million.
- Extraction revenue decreased 57%, from $34.3 million to $14.7 million.
- Gross margin improved substantially because the company reduced low-margin facility build-outs and generated a greater proportion of higher-margin extraction and software revenue.
- General and administrative expense decreased 74% to $19.0 million, largely due to lower bad-debt expense, personnel costs, stock-based compensation, depreciation, and insurance expense.
- The company recorded no goodwill or intangible-asset impairment in 2023, compared with a $69.9 million impairment charge in 2022. The 2022 charge fully impaired reported goodwill and intangible assets.
- Operating cash burn decreased but remained significant. Investing cash flow was positive primarily because of $10.5 million of proceeds from securities sales and $15.1 million of loan repayments.
- Debt declined from $32.7 million at year-end 2022 to $21.3 million at year-end 2023, although related-party debt of $4.4 million was added and liquidity remained severely constrained.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
Management did not provide formal numerical revenue or earnings guidance. The company stated that it does not intend to enter into new total turnkey solutions for the foreseeable future, while focusing on completing existing projects, expanding its Rapid Deployment Pack program, growing extraction sales, and reducing costs.
- Going concern: Continued operations depend on additional debt or equity financing and eventual positive operating cash flow. Management stated that it may need to sell assets or business lines, pursue a business combination, or reduce or terminate operations if financing is unavailable.
- Subsequent financing: In February 2024, Agrify raised approximately $2.2 million of net proceeds through an offering of common stock and pre-funded warrants. Management indicated that additional capital would be needed to support 2024 and 2025 funding requirements.
- Debt restructuring and related parties: In January 2024, debt owed to the CEO-affiliated lender was consolidated into a restated convertible note. The restated note had approximately $18.9 million of principal before a $3.9 million conversion, leaving approximately $15.0 million outstanding. It carries a 10% interest rate, matures December 31, 2025, and has a conversion price of $1.46 per share.
- Nasdaq compliance: The company received notices regarding delinquent filings, negative stockholders’ equity, and a bid price below $1.00. Nasdaq granted an exception through April 15, 2024 for the equity deficiency, while the bid-price compliance period was scheduled to expire September 3, 2024. The filing states that continued listing was not assured.
- Internal controls: Management concluded that disclosure controls and internal control over financial reporting were ineffective as of December 31, 2023. Material weaknesses involved timely closing, insufficient technical accounting expertise, complex financial instruments, segregation of duties, and finance personnel departures.
- TTK receivables and litigation: The company maintained allowances of $14.7 million for Bud & Mary’s and $4.5 million for Hannah. Bud & Mary’s litigation includes claims against Agrify, and Bowdoin Construction alleged approximately $6.3 million in unpaid construction obligations.
- Supplier settlement: Agrify settled a dispute with Mack Molding involving approximately $8.24 million, agreed to payments and future minimum VFU purchases, and issued warrants to purchase 750,000 shares at an exercise price of $4.00 per share.
- Equity dilution: At December 31, 2023, 5.38 million warrants were outstanding. The January 2024 debt conversion and February 2024 offering further increased potential dilution.
- Industry risk: Demand depends heavily on the cannabis industry, which remains subject to changing state laws, federal prohibition, licensing requirements, banking restrictions, customer failures, and regulatory uncertainty.
Most Important Facts for Investors to Verify
- Confirm that the intended issuer is Agrify Corporation rather than RYTHM, Inc.; the supplied filing identifies Agrify Corporation throughout.
- Verify the company’s ability to raise additional capital and fund operations given $0.4 million of cash, $41.2 million of current liabilities, negative operating cash flow, and the disclosed going-concern uncertainty.
- Review the terms, collateral, maturity, conversion provisions, ownership limitations, and related-party nature of the restated convertible note.
- Assess the status of Nasdaq’s equity and minimum-bid-price deficiencies and whether the common stock remained listed after the stated compliance deadlines.
- Evaluate the material weaknesses in internal controls and the risk of delayed filings, restatements, or additional accounting errors.
- Review the collectability of TTK loan receivables, including the $14.7 million Bud & Mary’s allowance and $4.5 million Hannah allowance, and the related litigation outcomes.
- Reconcile the stated shares outstanding, warrants, pre-funded warrants, debt conversions, reverse stock splits, and potential dilution after the January and February 2024 transactions.